Current Version of LDT Draft Guidance Means Much Fewer and Lower Quality Tests for Patients, Says Elaine Lyon of ARUP
Jan 13, 2015•22 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Guest:
Elaine Lyon, Former President, AMP; Medical Director of Molecular Genetics, ARUP Laboratories
Bio and Contact Info
Listen (4:37) What is at stake here?
Listen (6:16) Is your message being heard?
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Elaine Lyon, Former President, AMP; Medical Director of Molecular Genetics, ARUP Laboratories
Bio and Contact Info
Listen (4:37) What is at stake here?
Listen (6:16) Is your message being heard?
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
For the best experience, listen in Metacast app for iOS or Android